1-14 of 14
Authors: Aijie Liu
Journal Article
NZB;NZW chimeras develop strong autoimmunity earlier than NZB/NZW F1 Get access
The Journal of Immunology, Volume 200, Issue Supplement_1, May 2018, Page 40.6, https://doi.org/10.4049/jimmunol.200.Supp.40.6
Published: 01 May 2018
Journal Article
Age and sex affect αCTLA-4 efficacy alone and combined with αB7-H1 or regulatory T cell depletion in a melanoma model. Get access
The Journal of Immunology, Volume 196, Issue 1_Supplement, May 2016, Page 213.4, https://doi.org/10.4049/jimmunol.196.Supp.213.4
Published: 01 May 2016
Journal Article
Age effects on tumor B7-H1 and related immune therapies in an aggressive model of ovarian cancer. Get access
The Journal of Immunology, Volume 196, Issue 1_Supplement, May 2016, Page 211.19, https://doi.org/10.4049/jimmunol.196.Supp.211.19
Published: 01 May 2016
Journal Article
Mammalian target of rapamycin inhibition with enterically given rapamycin alters immunity and gut flora in young and aged wild type mice and extends life of immunodeficient mice (IRC8P.452) Get access
The Journal of Immunology, Volume 194, Issue 1_Supplement, May 2015, Page 129.16, https://doi.org/10.4049/jimmunol.194.Supp.129.16
Published: 01 May 2015
Journal Article
Anti-CD25 antibody and denileukin diftitox deplete regulatory T cells in ID8 ovarian cancer equally, but αCD25 promotes more T cell cytotoxicity that correlates with better survival (VAC12P.1112) Get access
The Journal of Immunology, Volume 194, Issue 1_Supplement, May 2015, Page 213.3, https://doi.org/10.4049/jimmunol.194.Supp.213.3
Published: 01 May 2015
Journal Article
Denileukin diftitox reduces EL4 lymphoma growth by depleting regulatory T cells, which can be improved by αICOS (VAC12P.1116) Get access
The Journal of Immunology, Volume 194, Issue 1_Supplement, May 2015, Page 213.7, https://doi.org/10.4049/jimmunol.194.Supp.213.7
Published: 01 May 2015
Journal Article
Oral rapamycin (eRapa) requires IFN-γ and promotes γδ T cell cytotoxicity to prevent carcinogen and inflammation-induced dermal cancer (TUM9P.1003) Get access
The Journal of Immunology, Volume 194, Issue 1_Supplement, May 2015, Page 210.5, https://doi.org/10.4049/jimmunol.194.Supp.210.5
Published: 01 May 2015
Journal Article
Mammalian target of rapamycin inhibitors are promising T cell lymphoma treatment agents that synergize with ERβ agonists in vitro but not in vivo (VAC3P.1061) Get access
The Journal of Immunology, Volume 194, Issue 1_Supplement, May 2015, Page 71.8, https://doi.org/10.4049/jimmunol.194.Supp.71.8
Published: 01 May 2015
Journal Article
Oral rapamycin (eRapa) safely prevents carcinogen-induced dermal carcinogenesis through an interferon-γ-dependent mechanism (TUM7P.931) Get access
The Journal of Immunology, Volume 192, Issue Supplement_1, May 2014, Page 203.13, https://doi.org/10.4049/jimmunol.192.Supp.203.13
Published: 01 May 2014
Journal Article
Interferon-α augments the clinical efficacy of regulatory T cell depletion in ovarian cancer through direct and indirect T cell effects (VAC3P.941) Get access
The Journal of Immunology, Volume 192, Issue Supplement_1, May 2014, Page 73.3, https://doi.org/10.4049/jimmunol.192.Supp.73.3
Published: 01 May 2014
Journal Article
Effective age-specific tumor immunotherapy for B16 melanoma by targeting age-related immune dysfunction (46.42) Get access
The Journal of Immunology, Volume 188, Issue 1_Supplement, May 2012, Page 46.42, https://doi.org/10.4049/jimmunol.188.Supp.46.42
Published: 01 May 2012
Journal Article
Targeting CD73 to improves tumor immunotherapy (131.23) Get access
The Journal of Immunology, Volume 184, Issue Supplement_1, April 2010, Page 131.23, https://doi.org/10.4049/jimmunol.184.Supp.131.23
Published: 01 April 2010
Journal Article
Interleukin-12 is dispensable for functional interferon (IFN)-gamma producing CD8+ cytotoxic T cells in Toxoplasma gondii infection (133.28) Get access
The Journal of Immunology, Volume 182, Issue Supplement_1, April 2009, Page 133.28, https://doi.org/10.4049/jimmunol.182.Supp.133.28
Published: 01 April 2009
Journal Article
CD73 on tumor cells impairs anti-tumor T cell immunity: a novel mechanism of tumor-induced immune suppression (40.17) Get access
The Journal of Immunology, Volume 182, Issue Supplement_1, April 2009, Page 40.17, https://doi.org/10.4049/jimmunol.182.Supp.40.17
Published: 01 April 2009
